Published on May 26, 2010 at 3:03 AM
United Therapeutics Corporation and Lung Rx, LLC announced today the launch of a nationwide support program for patients who are currently prescribed a United Therapeutics therapy, which includes Remodulin (treprostinil) Injection, Adcirca (tadalafil) tablets or Tyvaso (treprostinil) Inhalation Solution.
Living PAH is a community made up of physicians, nurses, therapists and patients designed to provide disease education, emotional support and reimbursement assistance to those living with pulmonary arterial hypertension (PAH) and their caregivers. As part of Living PAH, patients have access to disease education, healthy lifestyle tips, news and support including help with access to therapies. A national call center (877-948-9137) is staffed Monday through Friday with registered nurses and operators available for patients to find answers to their questions about PAH, United Therapeutics products, additional support services and educational events designed to connect and empower patients and caregivers across the country.
To learn more about Living PAH, or to enroll, please contact the Living PAH Call Center at 877-948-9137 or visit livingpah.com. The Adcirca Reimbursement Hotline, 877-948-9136, will also continue to be a resource for patients and health care providers to provide insurance benefits investigation, reimbursement assistance and other support.
SOURCE United Therapeutics Corporation